Home/Advance Pharmaceutical/Dr. Maria Fernandez, Ph.D.
DM

Dr. Maria Fernandez, Ph.D.

Scientific Advisor, Genetics

Advance Pharmaceutical

Therapeutic Areas

Advance Pharmaceutical Pipeline

DrugIndicationPhase
AP-101Non-Small Cell Lung Cancer (NSCLC) with specific mutationsPhase 2
AP-202Advanced Solid TumorsPhase 1/2
AP-301Genetic Disorder AlphaPhase 1/2
AP-401Oncology (undisclosed target)Preclinical
AP-501Rare Metabolic DiseasePreclinical